PMID- 28806500 OWN - NLM STAT- MEDLINE DCOM- 20180619 LR - 20180620 IS - 1932-8494 (Electronic) IS - 1932-8486 (Linking) VI - 300 IP - 12 DP - 2017 Dec TI - Doxepin Mitigates Noise-induced Neuronal Damage in Primary Auditory Cortex of Mice via Suppression of Acid Sphingomyelinase/Ceramide Pathway. PG - 2220-2232 LID - 10.1002/ar.23677 [doi] AB - Neuronal damage in primary auditory cortex (A1) underlies complex manifestations of noise exposure, prevention of which is critical for health maintenance. Acid sphingomyelinase (ASM) catalyzes generation of ceramide (Cer) which if over-activated mediates neuronal disorders in various diseases. Tricyclic antidepressants (TCAs), by restraining ASM/Cer, benefits multiple neuronal anomalies, so we aimed to elucidate the effect of TCA on noise induced hearing loss and auditory cortex derangement, unraveling mechanism involved. The mice were exposed to noise with frequencies of 20-20 KHz and intensity of 95 dB. Doxepin hydrochloride (DOX), a kind of TCAs, was given intragastrically by 5 mg kg(-1) days(-1) . Morphology of neurons was examined using hematoxylin-eosin (HE) and Nissl staining. Apoptosis was assayed through transferase-mediated dUTP nick end labeling (TUNEL). The content of ASM, Cer or acid ceramidase (AC) was detected by western blot and immunohistochemistry analysis. We demonstrated intense, broad band noise caused upward shift of auditory brainstem response (ABR) threshold to sound over frequencies 4-32 KHz, with prominent morphologic changes and enhanced apoptosis in neurons of primary auditory cortex (A1) (P < 0.05). DOX partly restored noise-caused hearing loss alleviating morphologic changes or apoptosis remarkably (P < 0.05). Both ASM and Cer abundance were elevated significantly by noise which was reversed upon DOX treatment (P < 0.05), but neither noise nor DOX altered AC content. DOX had no influence on hearing, neuronal morphology or ASM/Cer in control mice. Our result suggests DOX palliates noise induced hearing loss and neuronal damage in auditory cortex by correcting over-activation of ASM/Cer without hampering intrinsic behavior of it. Anat Rec, 300:2220-2232, 2017. (c) 2017 Wiley Periodicals, Inc. CI - (c) 2017 Wiley Periodicals, Inc. FAU - Su, Yu-Ting AU - Su YT AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Meng, Xing-Xing AU - Meng XX AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Zhang, Xi AU - Zhang X AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Guo, Yi-Bin AU - Guo YB AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Zhang, Hai-Jun AU - Zhang HJ AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Cheng, Yao-Ping AU - Cheng YP AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Xie, Xiao-Ping AU - Xie XP AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Chang, Yao-Ming AU - Chang YM AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. FAU - Bao, Jun-Xiang AU - Bao JX AUID- ORCID: 0000-0001-5805-0543 AD - Department of Aerospace Hygiene, Fourth Military Medical University, Xi'an 710032, People's Republic of China. LA - eng PT - Journal Article DEP - 20170828 PL - United States TA - Anat Rec (Hoboken) JT - Anatomical record (Hoboken, N.J. : 2007) JID - 101292775 RN - 0 (Antidepressive Agents, Tricyclic) RN - 0 (Ceramides) RN - 1668-19-5 (Doxepin) RN - EC 3.1.4.12 (Sphingomyelin Phosphodiesterase) SB - IM MH - Acoustic Stimulation/adverse effects MH - Animals MH - Antidepressive Agents, Tricyclic/pharmacology/therapeutic use MH - Auditory Cortex/drug effects/*metabolism/pathology MH - Ceramides/antagonists & inhibitors/*metabolism MH - Doxepin/*pharmacology/therapeutic use MH - Hearing Loss, Noise-Induced/drug therapy/*metabolism/pathology MH - Male MH - Mice MH - Neurons/drug effects/metabolism/pathology MH - Noise/*adverse effects MH - Signal Transduction/drug effects/physiology MH - Sphingomyelin Phosphodiesterase/antagonists & inhibitors/*metabolism OTO - NOTNLM OT - acid sphingomyelinase OT - apoptosis OT - ceramide OT - noise OT - primary auditory cortex EDAT- 2017/08/15 06:00 MHDA- 2018/06/21 06:00 CRDT- 2017/08/15 06:00 PHST- 2017/03/12 00:00 [received] PHST- 2017/06/15 00:00 [revised] PHST- 2017/06/26 00:00 [accepted] PHST- 2017/08/15 06:00 [pubmed] PHST- 2018/06/21 06:00 [medline] PHST- 2017/08/15 06:00 [entrez] AID - 10.1002/ar.23677 [doi] PST - ppublish SO - Anat Rec (Hoboken). 2017 Dec;300(12):2220-2232. doi: 10.1002/ar.23677. Epub 2017 Aug 28.